Hansa Biopharma AB, Hansa or the Company today announced its full year and Q4 2024 financial results. Søren Tulstrup, President and CEO, Hansa Biopharma said, "2024 proved to be a transformative year ...
IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced ...
OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback